BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30674595)

  • 1. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems.
    Wilson RS; Yang J; Yu L; Leurgans SE; Capuano AW; Schneider JA; Bennett DA; Boyle PA
    Neurology; 2019 Feb; 92(8):e831-e840. PubMed ID: 30674595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal course of neurodegenerative effects on cognition in old age.
    Wilson RS; Capuano AW; Bennett DA; Schneider JA; Boyle PA
    Neuropsychology; 2016 Jul; 30(5):591-9. PubMed ID: 27111293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normative Cognitive Decline in Old Age.
    Wilson RS; Wang T; Yu L; Bennett DA; Boyle PA
    Ann Neurol; 2020 Jun; 87(6):816-829. PubMed ID: 32144793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 pathology, cognitive decline, and dementia in old age.
    Wilson RS; Yu L; Trojanowski JQ; Chen EY; Boyle PA; Bennett DA; Schneider JA
    JAMA Neurol; 2013 Nov; 70(11):1418-24. PubMed ID: 24080705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.
    Schneider JA; Arvanitakis Z; Yu L; Boyle PA; Leurgans SE; Bennett DA
    Brain; 2012 Oct; 135(Pt 10):3005-14. PubMed ID: 23065790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal dedifferentiation of cognitive abilities.
    Wilson RS; Segawa E; Hizel LP; Boyle PA; Bennett DA
    Neurology; 2012 Apr; 78(15):1116-22. PubMed ID: 22491858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study.
    Dawe RJ; Bennett DA; Schneider JA; Arfanakis K
    PLoS One; 2011; 6(10):e26286. PubMed ID: 22043314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death.
    Buciuc M; Tosakulwong N; Machulda MM; Whitwell JL; Weigand SD; Murray ME; Reichard RR; Parisi JE; Dickson DW; Boeve BF; Knopman DS; Petersen RC; Josephs KA
    J Alzheimers Dis; 2021; 80(2):683-693. PubMed ID: 33579840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes.
    Gicas KM; Honer WG; Wilson RS; Boyle PA; Leurgans SE; Schneider JA; Bennett DA
    Neurology; 2020 Dec; 95(24):e3303-e3312. PubMed ID: 33144516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.
    Nag S; Yu L; Capuano AW; Wilson RS; Leurgans SE; Bennett DA; Schneider JA
    Ann Neurol; 2015 Jun; 77(6):942-52. PubMed ID: 25707479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of neuropathology to cognition in persons without cognitive impairment.
    Bennett DA; Wilson RS; Boyle PA; Buchman AS; Schneider JA
    Ann Neurol; 2012 Oct; 72(4):599-609. PubMed ID: 23109154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons.
    Agrawal S; Yu L; Nag S; Arfanakis K; Barnes LL; Bennett DA; Schneider JA
    Acta Neuropathol Commun; 2021 Sep; 9(1):156. PubMed ID: 34563269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging.
    Kapasi A; Yu L; Boyle PA; Barnes LL; Bennett DA; Schneider JA
    Neurology; 2020 Oct; 95(14):e1951-e1962. PubMed ID: 32753441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between hippocampal microglia, AD and LATE-NC, and cognitive decline in older adults.
    Kapasi A; Yu L; Leurgans SE; Agrawal S; Boyle PA; Bennett DA; Schneider JA
    Alzheimers Dement; 2024 May; 20(5):3193-3202. PubMed ID: 38494787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing resources reduce the effect of Alzheimer pathology on other cognitive systems.
    Boyle PA; Wilson RS; Schneider JA; Bienias JL; Bennett DA
    Neurology; 2008 Apr; 70(17):1534-42. PubMed ID: 18354077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
    Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL
    Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline.
    Boyle PA; Yang J; Yu L; Leurgans SE; Capuano AW; Schneider JA; Wilson RS; Bennett DA
    Brain; 2017 Mar; 140(3):804-812. PubMed ID: 28082297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Aversion and Alzheimer Disease in Old Age.
    Wilson RS; Yu L; Schneider JA; Bennett DA; Boyle PA
    Am J Geriatr Psychiatry; 2019 Aug; 27(8):851-861. PubMed ID: 30982702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative disease and cognitive retest learning.
    Wilson RS; Capuano AW; Yu L; Yang J; Kim N; Leurgans SE; Lamar M; Schneider JA; Bennett DA; Boyle PA
    Neurobiol Aging; 2018 Jun; 66():122-130. PubMed ID: 29558667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.